News

Indiana University Health, part of AHA’s Living Learning Network, was able to overcome early supply chain challenges during the pandemic and help smaller health care neighbors in need, writes Dan Handel, M.D., vice president and chief medical officer for the health system’s south central region.

Sens. Elizabeth Warren, D-Mass., Cory Booker, D-N.J., and Ron Wyden, D-Ore., urged the Food and Drug Administration to review how accurately pulse oximeters monitor blood oxygen levels, citing multiple studies suggesting they provide misleading measures to patients of color.

New Jersey-based Atlantic Health System transformed how it recognizes and responds to human trafficking, becoming a model of success and helping make its communities safer.

South Carolina has reported the first documented U.S. cases of the SARS-CoV-2 variant first detected in South Africa, the Centers for Disease Control and Prevention announced.

President Biden signed an executive order aimed at increasing enrollment in comprehensive health care coverage.

In the midst of the tragedy that is the COVID-19 pandemic, one silver lining is how it has brought us together as an organization to help us innovate and realize our vision to make Indiana one of the healthiest states in the nation.

Registration is now open for the AHA’s Accelerating Health Equity virtual conference, March 16-18.

The AHA urged the Centers for Medicare & Medicaid Services to extend the deadline for hospitals to submit 2020 data for the Medicare Promoting Interoperability Program from March 1 to at least May 1, 2021, citing problems this year with the system used to submit the data.

The Food and Drug Administration announced an import alert on all alcohol-based hand sanitizers from Mexico, noting that 84% of those it analyzed from April through December 2020 did not comply with FDA regulations and more than half contained toxic ingredients at dangerous levels, including methanol or 1-propanol.

The Department of Health and Human Services today will amend the Public Readiness and Emergency Preparedness Act to permit doctors and nurses who have recently retired or become inactive to administer COVID-19 vaccines and anyone currently licensed to vaccinate in their state to administer shots across state lines, White House COVID-19 Response Coordinator Jeff Zients announced at the first regular briefing by the White House COVID-19 Response Team.

Ingrid Johnson, R.N., works with Atlantic Health System in Morristown, New Jersey, to raise awareness of human trafficking and how health care leaders can better identify victims and properly respond.

President Biden announced the federal government will purchase an additional 200 million doses of the two COVID-19 vaccines authorized by the Food and Drug Administration for emergency use.

Inspired by recent examples in sports and a Hamilton show tune, Kenneth Kaufman, managing director and chair of management consultancy KaufmanHall, challenges senior health care leaders to “make 2021 the year of true advancement in diversity, equity, and inclusion.”

The Joint Commission released for comment through Feb. 16 proposed new and revised workplace violence prevention standards for accredited hospitals and critical access hospitals.

The National Institutes of Health has launched an online data portal to collect clinical information on neurological symptoms, complications and outcomes related to COVID-19.

Drug maker Eli Lilly and Company said its neutralizing antibodies cocktail of bamlanivimab and etesevimab combine to significantly reduce hospitalizations and deaths attributed to COVID-19.

Regeneron Pharmaceuticals Inc. announced interim data indicating that its REGEN-COV antibody cocktail could be used as a passive vaccine to prevent COVID-19.

The public health emergency will likely remain in place through 2021, and the administration will give states 60 days’ notice before it decides to terminate the emergency or let it expire.

The Food and Drug Administration reissued emergency use authorizations for 10 systems authorized to decontaminate certain N95 respirators. 

Pfizer Inc. has completed enrolling children aged 12 to 15 in a COVID-19 vaccine study, the drug maker confirmed.